| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 891 | 937 | −4.9% |
| EBITDA | 170 | 266 | −36.1% |
| EBITDA margin | 19.1% | 28.4% | −9.3 pts |
| Profit before tax | 170 | 265 | −35.9% |
| Net profit | 126 | 192 | −34.3% |
| EPS | ₹38.90 | ₹59.17 | −34.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY27Jun 2026 | FY26Jun 2025 | FY25Jun 2024 | FY24Jun 2023 | FY23 and earlierAlpha Plus |
|---|
| 22,474 | — | — | — | — | FY23 and earlierEvery year the company has filed comes with Alpha Plus. | |
| — | — | — | 574 | 964 | ||
| 4,245 | 891 | 937 | 4,206 | 3,918 | ||
| — | −4.9% | −77.7% | +7.3% | — | ||
| 1,075 | 170 | 266 | 970 | 869 | ||
| 25.3% | 19.1% | 28.4% | 23.1% | 22.2% | ||
| 1,037 | 160 | 257 | 914 | 810 | ||
| 791 | 126 | 192 | 675 | 678 | ||
| 18.6% | 14.2% | 20.5% | 16.1% | 17.3% | ||
| ₹243.60 | ₹38.90 | ₹59.17 | ₹207.95 | ₹208.92 | ||
| — | −34.3% | −71.5% | −0.5% | — | ||
| — | — | — | 471 | 826 | ||
| — | — | — | −44.7 | −44.4 | ||
| — | — | — | 426 | 781 | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY24 30/06/2023 | FY25 30/06/2024 | FY26 30/06/2025 | FY27 30/06/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 22,473.7 | |
| - Cash, Equiv & ST Investments | 963.8 | 573.7 | — | — | — | |
| Revenue | 3,917.9 | 4,205.7 | 937.0 | 891.5 | 4,244.9 | |
| Growth %, YoY | — | +7.3 | -77.7 | -4.9 | — | |
| EBITDA | 868.6 | 970.2 | 266.2 | 170.1 | 1,074.9 | |
| Margin % | 22.17 | 23.07 | 28.41 | 19.08 | 25.32 | |
| EBIT | 810.3 | 913.7 | 257.1 | 160.5 | 1,037.0 | |
| Net Income | 678.1 | 675.0 | 192.1 | 126.3 | 790.7 | |
| Margin % | 17.31 | 16.05 | 20.50 | 14.16 | 18.63 | |
| EPS, Adj (current shares) | 208.92 | 207.95 | 59.17 | 38.90 | 243.60 | |
| Growth %, YoY | — | -0.5 | -71.5 | -34.3 | — | |
| Cash from Operations | 825.8 | 470.5 | — | — | — | |
| Capital Expenditures | -44.4 | -44.7 | — | — | — | |
| Free Cash Flow | 781.3 | 425.9 | — | — | — | |
Prices at the previous close · figures from the company's filings with NSE
Procter & Gamble Hygiene and Health Care (NSE: PGHH) had a market capitalisation of ₹22,474 crore at the previous close (₹6,923.50 a share), a PE ratio of 28.4 on the last four quarters' profit and a price-to-book ratio of 29.83. In the year to June 2026 its consolidated net profit was ₹126 crore on revenue of ₹891 crore. It had no borrowings on 31 March 2026. Promoters held 70.64% of the shares on 30 September 2026.
Procter & Gamble Hygiene and Health Care's PE ratio is 28.4 at the previous close (₹6,923.50 a share): a market capitalisation of ₹22,474 crore divided by consolidated net profit of ₹791 crore over the last four quarters (Q2 FY26 to Q1 FY27). On the year to June 2026 net profit (₹126 crore) it is 178.0.
Procter & Gamble Hygiene and Health Care's price-to-book (PB) ratio is 29.83 at the previous close: a market capitalisation of ₹22,474 crore divided by shareholders' equity (book value) of ₹753 crore on 31 March 2026. That is a book value of ₹232.12 per share against a share price of ₹6,923.50.
Procter & Gamble Hygiene and Health Care's net worth — shareholders' equity in its consolidated balance sheet — was ₹753 crore on 31 March 2026, up 2.2% from ₹737 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹22,474 crore at the previous close.
Procter & Gamble Hygiene and Health Care's market capitalisation was ₹22,474 crore at the previous close: 3.25 crore shares at ₹6,923.50 each.
Yes. Procter & Gamble Hygiene and Health Care had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹568 crore of cash, bank balances and current investments.
Procter & Gamble Hygiene and Health Care's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹753 crore. A year earlier, on 31 March 2025, it was 0.00.
Procter & Gamble Hygiene and Health Care's book value per share was ₹232.12 on 31 March 2026: shareholders' equity of ₹753 crore divided by the 3.25 crore shares in issue, up 2.2% from ₹227.05 a year earlier. The share price at the previous close was ₹6,923.50.
Procter & Gamble Hygiene and Health Care's basic earnings per share (EPS) were ₹38.90 in the year to June 2026, against ₹59.17 in the year to June 2025. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹243.59.
Procter & Gamble Hygiene and Health Care's latest results are for Q1 FY27 (April–June 2026), filed on 29 July 2026: consolidated net profit ₹126 crore, down 34.3% from ₹192 crore in Q1 FY26; revenue from operations ₹891 crore, down 4.9% year on year.
Procter & Gamble Hygiene and Health Care's dividend yield is 3.68% at the previous close: dividends of ₹255 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹6,923.50. They were ₹60 on 1 September 2026 and ₹195 on 5 February 2026 (interim + special).
In 2026, Procter & Gamble Hygiene and Health Care has declared two dividends totalling ₹255 a share: ₹195 (interim + special) with record date 5 February 2026 and ₹60 with record date 1 September 2026.
In the year to June 2026 (July 2025–June 2026), Procter & Gamble Hygiene and Health Care's consolidated net profit was ₹126 crore, down 34.3% from ₹192 crore in the year to June 2025, on revenue from operations of ₹891 crore (down 4.9%). Over three years, from the year to June 2023, net profit was down 81.4%.
Promoters held 70.64% of Procter & Gamble Hygiene and Health Care on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
On 30 September 2026, Procter & Gamble Hygiene and Health Care's shares were held by promoters 70.64%, foreign portfolio investors (FII/FPI) 0.62%, domestic institutions (DII) 15.04% (including mutual funds at 7.41%) and retail and other non-institutional investors 13.70%. Over the year, FII holding was down 0.49 percentage points from 1.11% and DII holding was down 1.02 percentage points from 16.06%.
Procter & Gamble Hygiene and Health Care will announce its Q2 FY27 results (July–September 2026) on Thursday, 12 November 2026, the date of the board meeting it has notified to the exchanges.
From Procter & Gamble Hygiene and Health Care's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.